Loading...

Anti-IL-5 Biologicals Targeting Severe Late Onset Eosinophilic Asthma

Improved knowledge about the pathogenesis of asthma has facilitated the development of novel drugs and provided hope for patients with severe asthma. After the short- and long-term success of omalizumab in severe allergic phenotype, researchers have targeted patients with severe eosinophilic asthma...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Turk Thorac J
Main Authors: Özyiğit, Leyla Pur, Öztürk, Ayşe Bilge, Bavbek, Sevim
Format: Artigo
Sprog:Inglês
Udgivet: Turkish Thoracic Society 2020
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7020889/
https://ncbi.nlm.nih.gov/pubmed/32163366
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/TurkThoracJ.2019.180204
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!